Atrial septal defects: Pattern, clinical profile, surgical techniques and outcome at Innova heart hospital: A 4-year

Daberechi K Adiele1, Josephat M Chinawa1, Ijeoma O Arodiwe1

  • 1Department of Paediatrics, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.

Insights

Transcatheter closure of atrial septal defect (ASD) in children demonstrates a high success rate. This minimally invasive procedure effectively treats this common congenital heart disease, improving patient outcomes.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Interventional Cardiology

Background:

  • Atrial septal defect (ASD) is a congenital heart defect causing abnormal blood flow between the atria.
  • While surgical repair is traditional, transcatheter closure is an increasingly utilized non-surgical option.
  • ASD can range from asymptomatic to presenting with heart failure.

Purpose of the Study:

  • To evaluate the outcomes of transcatheter closure for atrial septal defects in a pediatric population.
  • To assess the safety and efficacy of device closure for ASD.
  • To analyze the morphological characteristics of ASDs treated with transcatheter methods.

Main Methods:

  • Retrospective analysis of pediatric patients undergoing transcatheter ASD closure.
  • Echocardiographic assessment of complications at 24 hours, 1, 3, and 6 months post-procedure.
  • Evaluation of ASD morphology including diameter, location, shape, and septal margins.

Main Results:

  • Sixty-nine children with ASD were treated between 2007 and 2011.
  • A significant proportion (63.8%) presented with heart failure symptoms, and many had large ASDs (68.1%).
  • Searcare Heart® and Amplatzer® techniques were commonly used, with high success rates observed, particularly in 2010.

Conclusions:

  • Transcatheter closure is a highly successful intervention for atrial septal defects in children.
  • This minimally invasive approach offers an effective treatment for a common congenital heart condition.
  • The study highlights the favorable outcomes associated with device closure of ASDs.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753